What is the current Price Target for the Medicenna Therapeutics Corp stock?

The average Medicenna Therapeutics Corp target price is $2.89. This is 313.04% higher than the current stock price. The highest price target is 824.39%, the lowest is 270.50%. 6 Analysts have issued a price target Medicenna Therapeutics Corp 2026 .

How high will the Medicenna Therapeutics Corp stock rise?

No reliable answer can be given as to how high the Medicenna Therapeutics Corp stock will rise. The performance of stocks, including the Medicenna Therapeutics Corp stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Medicenna Therapeutics Corp stock today?

The performance of Medicenna Therapeutics Corp stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Medicenna Therapeutics Corp stock fall?

The decline in Medicenna Therapeutics Corp stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Medicenna Therapeutics Corp Forecast, price target & analysts

$0.70

0.71%

Nasdaq, Wed, Dec 24 2025

ISIN

CA58490H1073

Symbol

MDNA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Medicenna Therapeutics Corp Target price 2025 - Analyst rating & recommendation

Medicenna Therapeutics Corp Classifications & Recommendation:

Buy

90%

Hold

10%

Medicenna Therapeutics Corp Price Target

Target Price	$2.89
Price	$0.70
Potential	313.04% register free of charge
Number of Estimates	6

	6 Analysts have issued a price target Medicenna Therapeutics Corp 2026 . The average Medicenna Therapeutics Corp target price is $2.89. This is 313.04% register free of charge higher than the current stock price. The highest price target is $6.47 824.39% register free of charge , the lowest is $2.59 270.50% register free of charge .
	A rating was issued by 10 analysts: 9 Analysts recommend Medicenna Therapeutics Corp to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Medicenna Therapeutics Corp stock has an average upside potential 2026 of 313.04% register free of charge . Most analysts recommend the Medicenna Therapeutics Corp stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Mar '25	2026 Estimates
Earnings Per Share $	-0.11	-0.18
	59.26%	63.64%
P/E		negative

6 Analysts have issued a Medicenna Therapeutics Corp forecast for earnings per share. The average Medicenna Therapeutics Corp EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2025	$-0.11	59.26%
2026	$-0.18 63.64% Unlock
2027	$-0.33 83.33% Unlock
2028	$-0.50 51.52% Unlock

Current	-5.83	18.64%
2026	-3.99 31.60% Unlock
2027	-2.13 46.62% Unlock
2028	-1.41 33.80% Unlock

Medicenna Therapeutics Corp...

Current Medicenna Therapeutics Corp Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
BLOOM BURTON & CO.	Locked ➜ Locked	Locked	Dec 11 2025
LUCID CAPITAL MARKETS, LLC	Locked ➜ Locked	Locked	Dec 10 2025
RESEARCH CAPITAL CORPORATION	Locked ➜ Locked	Locked	Dec 10 2025
H.C. WAINWRIGHT & CO., LLC	Locked ➜ Locked	Locked	Aug 04 2025
RESEARCH CAPITAL CORPORATION	Locked ➜ Locked	Locked	Aug 01 2025
RESEARCH CAPITAL CORPORATION	Locked ➜ Locked	Locked	Jun 26 2025
RESEARCH CAPITAL CORPORATION	Locked ➜ Locked	Locked	Jun 25 2025

Analyst Rating	Date
Locked BLOOM BURTON & CO.: Locked ➜ Locked	Dec 11 2025
Locked LUCID CAPITAL MARKETS, LLC: Locked ➜ Locked	Dec 10 2025
Locked RESEARCH CAPITAL CORPORATION: Locked ➜ Locked	Dec 10 2025
Locked H.C. WAINWRIGHT & CO., LLC: Locked ➜ Locked	Aug 04 2025
Locked RESEARCH CAPITAL CORPORATION: Locked ➜ Locked	Aug 01 2025
Locked RESEARCH CAPITAL CORPORATION: Locked ➜ Locked	Jun 26 2025
Locked RESEARCH CAPITAL CORPORATION: Locked ➜ Locked	Jun 25 2025

Discover more stocks with a high price target

Coinbase Global, Inc. 70.19%

Netflix 51.41%

BioNTech SE - ADR 50.27%

Deutsche Telekom 41.05%

Alibaba Group Holding Ltd 40.63%

Uber Technologies 38.26%

Adyen 36.45%

PayPal 35.91%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now